Traumatic brain injury
Drug research and approvals for traumatic brain injury: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 375 studies of traumatic brain injury are recruiting on ClinicalTrials.gov, Health Canada has authorized 12 drug trials for it since 2013, and FDA has 0 approved and 4 open orphan designations naming it.
- Recruiting worldwide: 375
- Trials authorized in Canada: 12
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 375 recruiting on ClinicalTrials.gov ↗- Effects of Moderate/Severe Traumatic Brain Injury in the Subacute or Chronic Phase on Locomotor Strategies Involved in…NCT07230002 · Not applicable · Pôle Saint Hélier · starts Jan 4, 2027
- Carbon Dioxide Administration and Brain Waste ClearanceNCT07357090 · Not applicable · Andrew Mayer · starts Nov 10, 2026
- Home-Based Exergame Motor-Cognitive Rehabilitation for Traumatic Brain InjuryNCT07733336 · Not applicable · Fondazione Don Carlo Gnocchi ETS · starts Nov 9, 2026
- Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryNCT07935278 · Phase 2 · HealthPartners Institute · starts Nov 1, 2026
- Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)NCT07890337 · Phase 1 · Johns Hopkins University · starts Nov 1, 2026
- Sleep to Predict Recovery In Unconscious Patients With Acute Brain InjuryNCT07794605 · Not reported · Columbia University · starts Oct 30, 2026
- Smartphone Enabled Detection of Cognitive Motor Dissociation in the ICUNCT07917728 · Not reported · Columbia University · starts Oct 27, 2026
- Deployment of a Novel National Institute of Neurological Disorders and Stroke Clinical, Biomarker, Imaging, and…NCT07858266 · Not reported · University of Michigan · starts Oct 20, 2026
- The PIONEER Comparative Effectiveness Study - Project 2NCT07829107 · Not applicable · University of Michigan · starts Oct 15, 2026
- Overground Virtual Reality (VR) Gait Rehabilitation for Traumatic Brain Injury (TBI)NCT07038889 · Not applicable · Indiana University · starts Oct 9, 2026
Trials Authorized in Canada
The 10 newest of 12; search them all in Canada trials| Aug 15, 2025 | Brainapt – tbi international adaptative platform trialMETOPROLOL / PROPRANOLOL / PHENYTOIN / LEVETIRACETAM | CHU DE QUÉBEC-UNIVERSITÉ LAVAL | Ongoing |
| Oct 10, 2024 | Psilocybin-assisted therapy for chronic traumatic brain injuryPSILOCYBIN | ROOTS TO THRIVE | Pending |
| Sep 26, 2023 | Effects of dexmedetomidine on agitation in critically ill tbi patients (dex-tbi)DEXMEDETOMIDINE | CIUSSS DU NORD-DE-L'ILE-DE-MONTRÉAL - HÔPITAL DU SACRÉ-COEUR DE MONTRÉAL. | Ongoing |
| May 22, 2019 | Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of nt 201 in the treatment of lower limb…XEOMIN (NT 201) | Merz Group | Closed |
| Sep 26, 2018 | Mao-b imaging in traumatic brain injury[11C]-SL25.1188 INJ | PET CENTRE CENTRE FOR ADDICTION AND MENTAL HEALTH | Ongoing |
| Jul 19, 2018 | Hyperbaric oxygen brain injury treatment (hobit) trial: a multicenter, randomized, prospective phase II adaptive clinical trial evaluating the most effective…OXYGEN | MINNEAPOLIS MEDICAL RESEARCH FOUNDATION | Ongoing |
| May 11, 2017 | Prophylaxis for venous thromboembolism in severe traumatic brain injury, a double-blind randomized controlled trialFRAGMIN / LOVENOX / HEPARIN | SUNNYBROOK RESEARCH INSTITUTE | Ongoing |
| Nov 26, 2015 | Mechanism of amantadine and functional improvement following acquired brain injury as measured by mri tractography; a pilot studyAMANTADINE | HAMILTON HEALTH SCIENCES CORPORATION | Pending |
| Apr 23, 2015 | Prehospital tranexamic acid use for traumatic brain injuryTRANEXAMIC ACID | DR JIM CHRISTENSON | Ongoing |
| Mar 20, 2014 | Prehospital tranexamic acid use for traumatic brain injuryTRANEXAMIC ACID | ST MICHAELS HOSPITAL | Closed |
FDA Orphan Designations
Approved first, then open designations, newest first| Nov 23, 2010 | cyclosporine; ciclosporinTreatment of moderate to severe traumatic brain injury. | Owl Therapeutics | Designated |
| May 23, 2006 | Apomorphine hydrochlorideFor the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain… | NeuroHealing Pharmaceuticals, Inc. | Designated |
| Apr 15, 2005 | AnatibantTreatment of patients having experienced a severe traumatic brain injury (Glasgow Coma Scale 3 to 8) in order to decrease early mortality… | Xytis, Inc. | Designated |
| Aug 11, 2004 | dexanabinolFor the attenuation or amelioration of the long-term neurological sequelae associated with moderate and severe traumatic brain injury | Pharmos Corporation | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA